Market Cap | ₹6,691Cr |
ROE | 16.74% |
P/E Ratio(TTM) | 63.57 |
EPS(TTM) | 19.86 |
P/B Ratio | 13.60 |
Dividend Yield | 1.66% |
Industry P/E | 68.08 |
Book Value | 92.81 |
Debt to Equity | 0.05 |
Face Value | 10 |
Parent Organisation | Thyrocare Technologies |
Managing Director | Mr. Rahul Guha |
NSE Symbol | THYROCARE |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Dr Lal PathLabs | NA (0.00%) | 50.02 | ||
Metropolis Healthcare | NA (0.00%) | 67.89 | ||
Vijaya Diagnostic Centre | NA (0.00%) | 66.84 | ||
Krsnaa Diagnostics | NA (0.00%) | 33.42 |